0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Solid Tumor Drug Market Insights, Forecast to 2027
Published Date: September 2021
|
Report Code: QYRE-Auto-19N6828
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global and Japan Solid Tumor Drug Market Insights Forecast to 2027

Global and Japan Solid Tumor Drug Market Insights, Forecast to 2027

Code: QYRE-Auto-19N6828
Report
September 2021
147 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Solid Tumor Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Solid Tumor Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

Small Molecules
Biologics

Segment by Application

Oncology
Neurology
Radiology
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
1 Study Coverage
1.1 Solid Tumor Drug Product Introduction
1.2 Market by Type
1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Solid Tumor Drug Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Solid Tumor Drug Market Size, Estimates and Forecasts
2.1.1 Global Solid Tumor Drug Revenue 2016-2027
2.1.2 Global Solid Tumor Drug Sales 2016-2027
2.2 Global Solid Tumor Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Solid Tumor Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Solid Tumor Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Solid Tumor Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Solid Tumor Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Solid Tumor Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Solid Tumor Drug Revenue Forecast by Region (2022-2027)
3 Global Solid Tumor Drug Competitor Landscape by Players
3.1 Global Top Solid Tumor Drug Manufacturers by Sales
3.1.1 Global Solid Tumor Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Solid Tumor Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Solid Tumor Drug Manufacturers by Revenue
3.2.1 Key Solid Tumor Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Solid Tumor Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Solid Tumor Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2020
3.2.6 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Solid Tumor Drug Price by Manufacturers
3.4 Global Solid Tumor Drug Manufacturing Base Distribution, Product Types
3.4.1 Solid Tumor Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Solid Tumor Drug Product Type
3.4.3 Date of International Manufacturers Enter into Solid Tumor Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Solid Tumor Drug Market Size by Type (2016-2021)
4.1.1 Global Solid Tumor Drug Sales by Type (2016-2021)
4.1.2 Global Solid Tumor Drug Revenue by Type (2016-2021)
4.1.3 Solid Tumor Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Solid Tumor Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Solid Tumor Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Solid Tumor Drug Revenue Forecast by Type (2022-2027)
4.2.3 Solid Tumor Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Solid Tumor Drug Market Size by Application (2016-2021)
5.1.1 Global Solid Tumor Drug Sales by Application (2016-2021)
5.1.2 Global Solid Tumor Drug Revenue by Application (2016-2021)
5.1.3 Solid Tumor Drug Price by Application (2016-2021)
5.2 Solid Tumor Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Solid Tumor Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Solid Tumor Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Solid Tumor Drug Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Solid Tumor Drug Market Size YoY Growth 2016-2027
6.1.1 Japan Solid Tumor Drug Sales YoY Growth 2016-2027
6.1.2 Japan Solid Tumor Drug Revenue YoY Growth 2016-2027
6.1.3 Japan Solid Tumor Drug Market Share in Global Market 2016-2027
6.2 Japan Solid Tumor Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Solid Tumor Drug Players by Sales (2016-2021)
6.2.2 Japan Top Solid Tumor Drug Players by Revenue (2016-2021)
6.3 Japan Solid Tumor Drug Historic Market Review by Type (2016-2021)
6.3.1 Japan Solid Tumor Drug Sales Market Share by Type (2016-2021)
6.3.2 Japan Solid Tumor Drug Revenue Market Share by Type (2016-2021)
6.3.3 Japan Solid Tumor Drug Price by Type (2016-2021)
6.4 Japan Solid Tumor Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Solid Tumor Drug Sales Forecast by Type (2022-2027)
6.4.2 Japan Solid Tumor Drug Revenue Forecast by Type (2022-2027)
6.4.3 Japan Solid Tumor Drug Price Forecast by Type (2022-2027)
6.5 Japan Solid Tumor Drug Historic Market Review by Application (2016-2021)
6.5.1 Japan Solid Tumor Drug Sales Market Share by Application (2016-2021)
6.5.2 Japan Solid Tumor Drug Revenue Market Share by Application (2016-2021)
6.5.3 Japan Solid Tumor Drug Price by Application (2016-2021)
6.6 Japan Solid Tumor Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Solid Tumor Drug Sales Forecast by Application (2022-2027)
6.6.2 Japan Solid Tumor Drug Revenue Forecast by Application (2022-2027)
6.6.3 Japan Solid Tumor Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Solid Tumor Drug Market Size YoY Growth 2016-2027
7.2 North America Solid Tumor Drug Market Facts & Figures by Country
7.2.1 North America Solid Tumor Drug Sales by Country (2016-2021)
7.2.2 North America Solid Tumor Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Solid Tumor Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Solid Tumor Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Solid Tumor Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Solid Tumor Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Solid Tumor Drug Market Size YoY Growth 2016-2027
9.2 Europe Solid Tumor Drug Market Facts & Figures by Country
9.2.1 Europe Solid Tumor Drug Sales by Country (2016-2021)
9.2.2 Europe Solid Tumor Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Solid Tumor Drug Market Size YoY Growth 2016-2027
10.2 Latin America Solid Tumor Drug Market Facts & Figures by Country
10.2.1 Latin America Solid Tumor Drug Sales by Country (2016-2021)
10.2.2 Latin America Solid Tumor Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Solid Tumor Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Solid Tumor Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Solid Tumor Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Solid Tumor Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Solid Tumor Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Biogen
12.2.1 Biogen Corporation Information
12.2.2 Biogen Description and Business Overview
12.2.3 Biogen Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biogen Solid Tumor Drug Products Offered
12.2.5 Biogen Recent Development
12.3 Baxter
12.3.1 Baxter Corporation Information
12.3.2 Baxter Description and Business Overview
12.3.3 Baxter Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter Solid Tumor Drug Products Offered
12.3.5 Baxter Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Corporation Information
12.4.2 Celgene Corporation Description and Business Overview
12.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Celgene Corporation Solid Tumor Drug Products Offered
12.4.5 Celgene Corporation Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Corporation Information
12.5.2 Abbott Laboratories Description and Business Overview
12.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Laboratories Solid Tumor Drug Products Offered
12.5.5 Abbott Laboratories Recent Development
12.6 Pfizer Inc
12.6.1 Pfizer Inc Corporation Information
12.6.2 Pfizer Inc Description and Business Overview
12.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Inc Solid Tumor Drug Products Offered
12.6.5 Pfizer Inc Recent Development
12.7 Amgen Limited & Amgen Ireland Limited
12.7.1 Amgen Limited & Amgen Ireland Limited Corporation Information
12.7.2 Amgen Limited & Amgen Ireland Limited Description and Business Overview
12.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Products Offered
12.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Corporation Information
12.8.2 Bristol-Myers Squibb Company Description and Business Overview
12.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bristol-Myers Squibb Company Solid Tumor Drug Products Offered
12.8.5 Bristol-Myers Squibb Company Recent Development
12.9 GlaxoSmithKline plc.
12.9.1 GlaxoSmithKline plc. Corporation Information
12.9.2 GlaxoSmithKline plc. Description and Business Overview
12.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline plc. Solid Tumor Drug Products Offered
12.9.5 GlaxoSmithKline plc. Recent Development
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Products Offered
12.10.5 F. Hoffmann-La Roche Ltd. Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Solid Tumor Drug Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Corporation Information
12.12.2 Johnson & Johnson Description and Business Overview
12.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Johnson & Johnson Products Offered
12.12.5 Johnson & Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Solid Tumor Drug Industry Trends
13.2 Solid Tumor Drug Market Drivers
13.3 Solid Tumor Drug Market Challenges
13.4 Solid Tumor Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Solid Tumor Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Small Molecules
    Table 3. Major Manufacturers of Biologics
    Table 4. Global Solid Tumor Drug Market Size Growth Rate by Application (2021-2027) & (K MT)
    Table 5. Global Solid Tumor Drug Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Solid Tumor Drug Sales by Regions (2016-2021) & (K MT)
    Table 7. Global Solid Tumor Drug Sales Market Share by Regions (2016-2021)
    Table 8. Global Solid Tumor Drug Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Solid Tumor Drug Sales Forecast by Region (2022-2027) & (K MT)
    Table 10. Global Solid Tumor Drug Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Solid Tumor Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Solid Tumor Drug Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Solid Tumor Drug Sales by Manufacturers (2016-2021) (K MT)
    Table 14. Global Solid Tumor Drug Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Solid Tumor Drug Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Solid Tumor Drug Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Solid Tumor Drug Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Solid Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Solid Tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Drug as of 2020)
    Table 20. Key Manufacturers Solid Tumor Drug Price (2016-2021) (USD/MT)
    Table 21. Solid Tumor Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Solid Tumor Drug Product Type
    Table 23. Date of International Manufacturers Enter into Solid Tumor Drug Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Solid Tumor Drug Sales by Type (2016-2021) (K MT)
    Table 26. Global Solid Tumor Drug Sales Share by Type (2016-2021)
    Table 27. Global Solid Tumor Drug Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Solid Tumor Drug Revenue Share by Type (2016-2021)
    Table 29. Solid Tumor Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
    Table 30. Global Solid Tumor Drug Sales Forecast by Type (2022-2027) & (K MT)
    Table 31. Global Solid Tumor Drug Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Solid Tumor Drug Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Solid Tumor Drug Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Solid Tumor Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
    Table 35. Global Solid Tumor Drug Sales by Application (2016-2021) (K MT)
    Table 36. Global Solid Tumor Drug Sales Share by Application (2016-2021)
    Table 37. Global Solid Tumor Drug Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Solid Tumor Drug Revenue Share by Application (2016-2021)
    Table 39. Solid Tumor Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
    Table 40. Global Solid Tumor Drug Sales Forecast by Application (2022-2027) & (K MT)
    Table 41. Global Solid Tumor Drug Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Solid Tumor Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Solid Tumor Drug Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Solid Tumor Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
    Table 45. Japan Solid Tumor Drug Sales (K MT) of Key Companies (2016-2021)
    Table 46. Japan Solid Tumor Drug Sales Share by Company (2016-2021)
    Table 47. Japan Solid Tumor Drug Revenue (US$ Million) by Company (2016-2021)
    Table 48. Japan Solid Tumor Drug Revenue Share by Company (2016-2021)
    Table 49. Japan Solid Tumor Drug Sales (K MT) by Type (2016-2021)
    Table 50. Japan Solid Tumor Drug Sales Share by Type (2016-2021)
    Table 51. Japan Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. Japan Solid Tumor Drug Price (USD/MT) by Type (2016-2021)
    Table 53. Japan Solid Tumor Drug Sales (K MT) by Type (2022-2027)
    Table 54. Japan Solid Tumor Drug Sales Share by Type (2022-2027)
    Table 55. Japan Solid Tumor Drug Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. Japan Solid Tumor Drug Revenue Share by Type (2022-2027)
    Table 57. Japan Solid Tumor Drug Price (USD/MT) by Type (2022-2027)
    Table 58. Japan Solid Tumor Drug Sales (K MT) by Application (2016-2021)
    Table 59. Japan Solid Tumor Drug Sales Share by Application (2016-2021)
    Table 60. Japan Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. Japan Solid Tumor Drug Price (USD/MT) by Application (2016-2021)
    Table 62. Japan Solid Tumor Drug Sales (K MT) by Application (2022-2027)
    Table 63. Japan Solid Tumor Drug Sales Share by Application (2022-2027)
    Table 64. Japan Solid Tumor Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. Japan Solid Tumor Drug Revenue Share by Application (2022-2027)
    Table 66. Japan Solid Tumor Drug Price (USD/MT) by Application (2022-2027)
    Table 67. North America Solid Tumor Drug Sales by Country (2016-2021) & (K MT)
    Table 68. North America Solid Tumor Drug Sales Market Share by Country (2016-2021)
    Table 69. North America Solid Tumor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Solid Tumor Drug Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Solid Tumor Drug Sales by Region (2016-2021) & (K MT)
    Table 72. Asia Pacific Solid Tumor Drug Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Solid Tumor Drug Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Solid Tumor Drug Revenue Market Share by Region (2016-2021)
    Table 75. Europe Solid Tumor Drug Sales by Country (2016-2021) & (K MT)
    Table 76. Europe Solid Tumor Drug Sales Market Share by Country (2016-2021)
    Table 77. Europe Solid Tumor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Solid Tumor Drug Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Solid Tumor Drug Sales by Country (2016-2021) & (K MT)
    Table 80. Latin America Solid Tumor Drug Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Solid Tumor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Solid Tumor Drug Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Solid Tumor Drug Sales by Country (2016-2021) & (K MT)
    Table 84. Middle East and Africa Solid Tumor Drug Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Solid Tumor Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Solid Tumor Drug Revenue Market Share by Country (2016-2021)
    Table 87. AstraZeneca Corporation Information
    Table 88. AstraZeneca Description and Business Overview
    Table 89. AstraZeneca Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 90. AstraZeneca Solid Tumor Drug Product
    Table 91. AstraZeneca Recent Development
    Table 92. Biogen Corporation Information
    Table 93. Biogen Description and Business Overview
    Table 94. Biogen Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 95. Biogen Product
    Table 96. Biogen Recent Development
    Table 97. Baxter Corporation Information
    Table 98. Baxter Description and Business Overview
    Table 99. Baxter Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 100. Baxter Product
    Table 101. Baxter Recent Development
    Table 102. Celgene Corporation Corporation Information
    Table 103. Celgene Corporation Description and Business Overview
    Table 104. Celgene Corporation Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 105. Celgene Corporation Product
    Table 106. Celgene Corporation Recent Development
    Table 107. Abbott Laboratories Corporation Information
    Table 108. Abbott Laboratories Description and Business Overview
    Table 109. Abbott Laboratories Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 110. Abbott Laboratories Product
    Table 111. Abbott Laboratories Recent Development
    Table 112. Pfizer Inc Corporation Information
    Table 113. Pfizer Inc Description and Business Overview
    Table 114. Pfizer Inc Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 115. Pfizer Inc Product
    Table 116. Pfizer Inc Recent Development
    Table 117. Amgen Limited & Amgen Ireland Limited Corporation Information
    Table 118. Amgen Limited & Amgen Ireland Limited Description and Business Overview
    Table 119. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 120. Amgen Limited & Amgen Ireland Limited Product
    Table 121. Amgen Limited & Amgen Ireland Limited Recent Development
    Table 122. Bristol-Myers Squibb Company Corporation Information
    Table 123. Bristol-Myers Squibb Company Description and Business Overview
    Table 124. Bristol-Myers Squibb Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 125. Bristol-Myers Squibb Company Product
    Table 126. Bristol-Myers Squibb Company Recent Development
    Table 127. GlaxoSmithKline plc. Corporation Information
    Table 128. GlaxoSmithKline plc. Description and Business Overview
    Table 129. GlaxoSmithKline plc. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 130. GlaxoSmithKline plc. Product
    Table 131. GlaxoSmithKline plc. Recent Development
    Table 132. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 133. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 134. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 135. F. Hoffmann-La Roche Ltd. Product
    Table 136. F. Hoffmann-La Roche Ltd. Recent Development
    Table 137. Eli Lilly and Company Corporation Information
    Table 138. Eli Lilly and Company Description and Business Overview
    Table 139. Eli Lilly and Company Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 140. Eli Lilly and Company Product
    Table 141. Eli Lilly and Company Recent Development
    Table 142. Johnson & Johnson Corporation Information
    Table 143. Johnson & Johnson Description and Business Overview
    Table 144. Johnson & Johnson Solid Tumor Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 145. Johnson & Johnson Product
    Table 146. Johnson & Johnson Recent Development
    Table 147. Solid Tumor Drug Market Trends
    Table 148. Solid Tumor Drug Market Drivers
    Table 149. Solid Tumor Drug Market Challenges
    Table 150. Solid Tumor Drug Market Restraints
    Table 151. Solid Tumor Drug Customers List
    Table 152. Solid Tumor Drug Distributors List
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Solid Tumor Drug Product Picture
    Figure 2. Global Solid Tumor Drug Sales Market Share by Type in 2020 & 2027
    Figure 3. Small Molecules Product Picture
    Figure 4. Biologics Product Picture
    Figure 5. Global Solid Tumor Drug Sales Market Share by Application in 2020 & 2027
    Figure 6. Oncology
    Figure 7. Neurology
    Figure 8. Radiology
    Figure 9. Others
    Figure 10. Solid Tumor Drug Report Years Considered
    Figure 11. Global Solid Tumor Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Solid Tumor Drug Market Size 2016-2027 (US$ Million)
    Figure 13. Global Solid Tumor Drug Sales 2016-2027 (K MT)
    Figure 14. Global Solid Tumor Drug Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Solid Tumor Drug Sales Market Share by Region (2016-2021)
    Figure 16. Global Solid Tumor Drug Sales Market Share by Region in 2020
    Figure 17. Global Solid Tumor Drug Revenue Market Share by Region (2016-2021)
    Figure 18. Global Solid Tumor Drug Revenue Market Share by Region in 2020
    Figure 19. Global Solid Tumor Drug Sales Share by Manufacturer in 2020
    Figure 20. The Top 10 and 5 Players Market Share by Solid Tumor Drug Revenue in 2020
    Figure 21. Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 22. Global Solid Tumor Drug Sales Market Share by Type (2016-2021)
    Figure 23. Global Solid Tumor Drug Sales Market Share by Type in 2020
    Figure 24. Global Solid Tumor Drug Revenue Market Share by Type (2016-2021)
    Figure 25. Global Solid Tumor Drug Revenue Market Share by Type in 2020
    Figure 26. Global Solid Tumor Drug Sales Market Share by Application (2016-2021)
    Figure 27. Global Solid Tumor Drug Sales Market Share by Application in 2020
    Figure 28. Global Solid Tumor Drug Revenue Market Share by Application (2016-2021)
    Figure 29. Global Solid Tumor Drug Revenue Market Share by Application in 2020
    Figure 30. Japan Solid Tumor Drug Sales Growth Rate 2016-2027 (K MT)
    Figure 31. Japan Solid Tumor Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Japan Solid Tumor Drug Market Share in Global Market 2016-2027
    Figure 33. Japan 5 and 10 Largest Solid Tumor Drug Players Market Share by Revenue in Solid Tumor Drug in 2020
    Figure 34. Japan Solid Tumor Drug Revenue Share by Type (2016-2021)
    Figure 35. Japan Solid Tumor Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 36. Japan Solid Tumor Drug Revenue Share by Application (2016-2021)
    Figure 37. Japan Solid Tumor Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 38. North America Solid Tumor Drug Sales Growth Rate 2016-2021 (K MT)
    Figure 39. North America Solid Tumor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 40. North America Solid Tumor Drug Sales Market Share by Country in 2020
    Figure 41. North America Solid Tumor Drug Revenue Market Share by Country in 2020
    Figure 42. U.S. Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 43. U.S. Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Canada Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 45. Canada Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Europe Solid Tumor Drug Sales Growth Rate 2016-2021 (K MT)
    Figure 47. Europe Solid Tumor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 48. Europe Solid Tumor Drug Sales Market Share by Country in 2020
    Figure 49. Europe Solid Tumor Drug Revenue Market Share by Country in 2020
    Figure 50. Germany Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 51. Germany Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. France Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 53. France Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. U.K. Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 55. U.K. Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Italy Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 57. Italy Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Russia Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 59. Russia Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Asia Pacific Solid Tumor Drug Sales Growth Rate 2016-2021 (K MT)
    Figure 61. Asia Pacific Solid Tumor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 62. Asia Pacific Solid Tumor Drug Sales Market Share by Region in 2020
    Figure 63. Asia Pacific Solid Tumor Drug Revenue Market Share by Region in 2020
    Figure 64. China Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 65. China Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Japan Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 67. Japan Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. South Korea Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 69. South Korea Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. India Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 71. India Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Australia Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 73. Australia Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. China Taiwan Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 75. China Taiwan Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Indonesia Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 77. Indonesia Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Thailand Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 79. Thailand Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Malaysia Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 81. Malaysia Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Latin America Solid Tumor Drug Sales Growth Rate 2016-2021 (K MT)
    Figure 83. Latin America Solid Tumor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 84. Latin America Solid Tumor Drug Sales Market Share by Country in 2020
    Figure 85. Latin America Solid Tumor Drug Revenue Market Share by Country in 2020
    Figure 86. Mexico Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 87. Mexico Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Brazil Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 89. Brazil Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Argentina Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 91. Argentina Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Middle East and Africa Solid Tumor Drug Sales Growth Rate 2016-2021 (K MT)
    Figure 93. Middle East and Africa Solid Tumor Drug Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 94. Middle East and Africa Solid Tumor Drug Sales Market Share by Country in 2020
    Figure 95. Middle East and Africa Solid Tumor Drug Revenue Market Share by Country in 2020
    Figure 96. Turkey Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 97. Turkey Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Saudi Arabia Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 99. Saudi Arabia Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. UAE Solid Tumor Drug Sales Growth Rate (2016-2021) (K MT)
    Figure 101. UAE Solid Tumor Drug Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Solid Tumor Drug Value Chain
    Figure 103. Channels of Distribution
    Figure 104. Distributors Profiles
    Figure 105. Bottom-up and Top-down Approaches for This Report
    Figure 106. Data Triangulation
    Figure 107. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global micro bioreactors market reserch report 2021
Global Micro bioreactors market research report 2021

120 Pages
Type: Report
Code: QYRE-Othe-1F481
Tue Oct 26 13:23:37 UTC 2021

Add to Cart

China ELISpot and FluoroSpot Assay Market Report Forecast 2021 2027
China ELISpot and FluoroSpot Assay Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-9X7111
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

China Digital PCR DPCR and QPCR Market Report Forecast 2021 2027
China Digital PCR (DPCR) and QPCR Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18O6996
Tue Oct 26 00:00:00 UTC 2021

Add to Cart

Global and United States Pharmaceutical Dryer Market Insights Forecast to 2027
Global and United States Pharmaceutical Dryer Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-25D6747
Mon Oct 25 00:00:00 UTC 2021

Add to Cart